相似文献
1
Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®).
Eur J Haematol. 2011 Mar;86(3):274-5. doi: 10.1111/j.1600-0609.2010.01569.x. Epub 2011 Jan 25.
2
Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
Int J Hematol. 2016 May;103(5):537-44. doi: 10.1007/s12185-016-1945-y. Epub 2016 Feb 9.
3
A case of well-tolerated and safe deferasirox administration during the first trimester of a spontaneous pregnancy in an advanced maternal age thalassemic patient.
Acta Haematol. 2011;125(4):222-4. doi: 10.1159/000323289. Epub 2011 Jan 27.
4
Compliance and satisfaction with deferasirox (Exjade®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia.
Hematology. 2014 Jun;19(4):187-91. doi: 10.1179/1607845413Y.0000000121. Epub 2013 Nov 25.
5
Treatment with deferasirox (Exjade) effectively decreases iron burden in patients with thalassaemia intermedia: results of a pilot study.
Br J Haematol. 2010 Jan;148(2):332-4. doi: 10.1111/j.1365-2141.2009.07930.x. Epub 2009 Oct 26.
6
Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.
Ann Hematol. 2010 Apr;89(4):405-9. doi: 10.1007/s00277-009-0838-z. Epub 2009 Oct 2.
7
Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia.
Br J Haematol. 2010 Dec;151(5):504-8. doi: 10.1111/j.1365-2141.2010.08346.x. Epub 2010 Oct 18.
8
Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies.
Br J Haematol. 2011 Sep;154(5):654-6. doi: 10.1111/j.1365-2141.2011.08626.x. Epub 2011 May 25.
9
Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia.
Hemoglobin. 2015;39(5):327-9. doi: 10.3109/03630269.2015.1057735. Epub 2015 Jun 26.
10
Current status of iron overload and chelation with deferasirox.
Indian J Pediatr. 2007 Aug;74(8):759-64. doi: 10.1007/s12098-007-0134-7.
引用本文的文献
1
Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy.
Am J Obstet Gynecol. 2024 Feb;230(2):B17-B40. doi: 10.1016/j.ajog.2023.10.031. Epub 2023 Oct 21.
2
Deferasirox in thalassemia: a comparative study between an innovator drug and its copy among a sample of Iraqi patients.
Ther Adv Drug Saf. 2019 Oct 9;10:2042098619880123. doi: 10.1177/2042098619880123. eCollection 2019.
3
Fertility in Patients with Thalassemia and Outcome of Pregnancies: A Turkish Experience.
Turk J Haematol. 2019 Nov 18;36(4):274-277. doi: 10.4274/tjh.galenos.2019.2019.0025. Epub 2019 Jun 14.
4
Pregnancy in Thalassemia.
Mediterr J Hematol Infect Dis. 2019 Mar 1;11(1):e2019019. doi: 10.4084/MJHID.2019.019. eCollection 2019.
5
Pregnancy in women with thalassemia: challenges and solutions.
Int J Womens Health. 2016 Sep 8;8:441-51. doi: 10.2147/IJWH.S89308. eCollection 2016.
6
Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
Int J Hematol. 2016 May;103(5):537-44. doi: 10.1007/s12185-016-1945-y. Epub 2016 Feb 9.
7
Pregnancy Outcomes in Women with Homozygous Beta Thalassaemia: A single-centre experience from Oman.
Sultan Qaboos Univ Med J. 2014 Aug;14(3):e337-41. Epub 2014 Jul 24.
本文引用的文献
1
Iron studies in infants born to an iron overloaded mother with beta-thalassemia major: possible effects of maternal desferrioxamine therapy.
J Pediatr Hematol Oncol. 2007 Mar;29(3):160-2. doi: 10.1097/MPH.0b013e31803b957d.
2
Pregnancy in patients treated for beta thalassemia major in two centers (Ali Asghar Children's Hospital and Thalassemia Clinic): outcome for mothers and newborn infants.
Pediatr Hematol Oncol. 2006 Jan-Feb;23(1):33-7. doi: 10.1080/08880010500313306.
3
Complications of beta-thalassemia major in North America.
Blood. 2004 Jul 1;104(1):34-9. doi: 10.1182/blood-2003-09-3167. Epub 2004 Feb 26.
4
Reproductive health in female patients with beta-thalassemia major.
Ann N Y Acad Sci. 2000;900:119-24. doi: 10.1111/j.1749-6632.2000.tb06222.x.
5
Fertility in thalassemia: the Greek experience.
J Pediatr Endocrinol Metab. 1998;11 Suppl 3:945-51.
6
Fertility in female patients with thalassemia.
J Pediatr Endocrinol Metab. 1998;11 Suppl 3:935-43.
7
Deferoxamine treatment during pregnancy: is it harmful?
Am J Hematol. 1999 Jan;60(1):24-6. doi: 10.1002/(sici)1096-8652(199901)60:1<24::aid-ajh5>3.0.co;2-c.
8
Transfusion-dependent homozygous beta-thalassaemia major: successful pregnancy in five cases.
Eur J Obstet Gynecol Reprod Biol. 1997 Aug;74(2):127-31. doi: 10.1016/s0301-2115(97)00089-4.
9
Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases.
Haematologica. 1993 May-Jun;78(3):183-4.
10
Fertility in beta thalassaemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature.
Br J Obstet Gynaecol. 1995 Aug;102(8):625-9. doi: 10.1111/j.1471-0528.1995.tb11400.x.
Zotero 插件